Skip to content

Application of Enhanced Recovery After Surgery (ERAS) program and traditional program in thoracoscopic cardiopulmonary bypass surgery: a single-center, randomized, single-blind prospective parallel controlled study based on perioperative safety

Application of Enhanced Recovery After Surgery (ERAS) program and traditional program in thoracoscopic cardiopulmonary bypass surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027240
Enrollment
Unknown
Registered
2019-11-06
Start date
2019-11-15
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart disease

Interventions

tranditional group:traditional program

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 70 years; 2) Indications for thoracoscopic cardiopulmonary bypass surgery; 3) EuroSCORE risk score <6 points; 4) Body mass index: 15~30 kg/m2; 5) Heart function classification is grade II-III (NYHA classification method); 6) Good cognitive status; 7) Fully understand the purpose of the clinical trial, and sign the informed consent form based on my wishes; 8) Being able to visit the hospital according to the date specified by the researcher and accept the guidance and inspection.

Exclusion criteria

Exclusion criteria: 1) Combined with coagulopathy, severe brain, liver, renal insufficiency, endocrine system diseases and serious infectious diseases; 2) The patient has a serious mental illness; 3) Emergency surgery; 4) Redo Surgery; 5) Suspected or indeed have a history of alcohol or drug abuse; 6) COPD (GOLD classification) >= 2, preoperative arterial blood oxygen partial pressure 45mmHg; 7) Severe pulmonary hypertension, hemodynamic instability; 8) Researchers believe that it is not appropriate for participants or patients who are unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frame
Readiness to discharge;Time of mechanical ventilation;ICU stay;Perioperative mortality;Perioperative adverse events;

Countries

China

Contacts

Public ContactSheng Wang

Guangdong Provincial People's Hospital

shengwang_gz@163.com+86 13560182353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026